These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 908140

  • 1. The urinary excretion of the nucleosides pseudouridine and 1-methylinosine during normal menstrual cycle.
    Lehtiö H, Mäenpää PH.
    Clin Chim Acta; 1977 Oct 01; 80(1):181-5. PubMed ID: 908140
    [Abstract] [Full Text] [Related]

  • 2. The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer.
    Waalkes TP, Gehrke CW, Zumwalt RW, Chang SY, Lakings DB, Tormey DC, Ahmann DL, Moertel CG.
    Cancer; 1975 Aug 01; 36(2):390-8. PubMed ID: 1157009
    [Abstract] [Full Text] [Related]

  • 3. Urinary excretion by cancer patients of the nucleosides N-dimethylguanosine, 1-methylinosine, and pseudouridine.
    Waalkes TP, Dinsmore SR, Mrochek JE.
    J Natl Cancer Inst; 1973 Jul 01; 51(1):271-4. PubMed ID: 4720877
    [No Abstract] [Full Text] [Related]

  • 4. Biological markers in breast carcinoma--clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosine.
    Tormey DC, Waalkes TP, Gehrke CW.
    J Surg Oncol; 1980 Jul 01; 14(3):267-73. PubMed ID: 7392649
    [Abstract] [Full Text] [Related]

  • 5. Quantitative determination of methylated nucleosides and pseudouridine in urine by gas-liquid chromatography.
    Chang SY, Lakings DB, Zumwalt RW, Gehrke CW, Waalkes TP.
    J Lab Clin Med; 1974 May 01; 83(5):816-30. PubMed ID: 4821860
    [No Abstract] [Full Text] [Related]

  • 6. Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemia.
    Heldman DA, Grever MR, Miser JS, Trewyn RW.
    J Natl Cancer Inst; 1983 Aug 01; 71(2):269-73. PubMed ID: 6576186
    [Abstract] [Full Text] [Related]

  • 7. Urinary excretion of modified nucleosides in chronic myelogenous leukemia.
    Heldman DA, Grever MR, Speicher CE, Trewyn RW.
    J Lab Clin Med; 1983 May 01; 101(5):783-92. PubMed ID: 6572681
    [Abstract] [Full Text] [Related]

  • 8. Relationship between urinary excretion of modified nucleosides and rheumatoid arthritis process.
    Tebib JG, Reynaud C, Cedoz JP, Letroublon MC, Niveleau A.
    Br J Rheumatol; 1997 Sep 01; 36(9):990-5. PubMed ID: 9376997
    [Abstract] [Full Text] [Related]

  • 9. A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breast.
    Woo KB, Waalkes TP, Ahmann DL, Tormey DC, Gehrke CW, Oliverio VT.
    Cancer; 1978 May 01; 41(5):1685-703. PubMed ID: 348295
    [Abstract] [Full Text] [Related]

  • 10. Correlations of pseudouridine in 8-hour and 24-hour urinary samples determined by high-performance liquid chromatography.
    Sjølin KE.
    Urol Res; 1982 May 01; 10(5):245-8. PubMed ID: 7164220
    [Abstract] [Full Text] [Related]

  • 11. Nucleoside excretion in breast cancer: comparison with other biochemical tumour-index-substances.
    Coombes RC, Powles TJ, Gehrke CW, Waalkes TP, Neville AM.
    Invest Cell Pathol; 1979 May 01; 2(1):11-4. PubMed ID: 511604
    [Abstract] [Full Text] [Related]

  • 12. Pseudouridine: a modified nucleoside as biological marker in malignant lymphomas.
    Rasmuson T, Björk GR.
    Cancer Detect Prev; 1983 May 01; 6(1-2):293-6. PubMed ID: 6883387
    [Abstract] [Full Text] [Related]

  • 13. Age dependence of human urinary pseudouridine excretion.
    Tritsch GL, Luch JM, Evans JT, Mittelman A.
    Biochem Med; 1979 Dec 01; 22(3):387-90. PubMed ID: 533544
    [No Abstract] [Full Text] [Related]

  • 14. Pyrimidine nucleoside, pseudouridine, and modified nucleoside excretion by growing and resting fibroblasts.
    Uziel M, Selkirk JK.
    J Cell Physiol; 1979 May 01; 99(2):217-22. PubMed ID: 457787
    [Abstract] [Full Text] [Related]

  • 15. Urinary excretion of pseudouridine in patients with hepatocellular carcinoma.
    Tamura S, Amuro Y, Nakano T, Fujii J, Moriwaki Y, Yamamoto T, Hada T, Higashino K.
    Cancer; 1986 Apr 15; 57(8):1571-5. PubMed ID: 2418945
    [Abstract] [Full Text] [Related]

  • 16. Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract.
    Koshida K, Harmenberg J, Stendahl U, Wahren B, Borgström E, Helström L, Andersson L.
    Urol Res; 1985 Apr 15; 13(5):213-8. PubMed ID: 4060364
    [Abstract] [Full Text] [Related]

  • 17. Urinary excretion of purines, purine nucleosides, and pseudouridine in immunodeficient children.
    Mills GC, Schmalstieg FC, Koolkin RJ, Goldblum RM.
    Biochem Med; 1982 Feb 15; 27(1):37-45. PubMed ID: 7115356
    [No Abstract] [Full Text] [Related]

  • 18. Quantitation of urinary nucleosides by high-performance liquid chromatography.
    Liebich HM, Di Stefano C, Wixforth A, Schmid HR.
    J Chromatogr A; 1997 Feb 28; 763(1-2):193-7. PubMed ID: 9129323
    [Abstract] [Full Text] [Related]

  • 19. Urinary excretion of purines, purine nucleosides, and pseudouridine in adenosine deaminase deficiency.
    Mills GC, Goldblum RM, Newkirk KE, Schmalstieg FC.
    Biochem Med; 1978 Oct 28; 20(2):180-99. PubMed ID: 736910
    [No Abstract] [Full Text] [Related]

  • 20. [Interrelationship of pseudouridine and transfer RNA metabolic disorders in thermal injury].
    Salomatin VV, Efimenko GP, Kamilov FKh, Lifshits RI.
    Vopr Med Khim; 1977 Oct 28; 23(5):642-6. PubMed ID: 595499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.